Herpes simplex virus type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants.

PubWeight™: 2.44‹?› | Rank: Top 2%

🔗 View Article (PMC 237693)

Published in J Virol on June 01, 1993

Authors

L A Tengelsen1, N E Pederson, P R Shaver, M W Wathen, F L Homa

Author Affiliations

1: Upjohn Company, Kalamazoo, Michigan 49001.

Articles citing this

Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol (1994) 3.24

The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA. J Virol (1998) 2.81

Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J Virol (1998) 2.53

Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J Virol (1998) 2.41

Herpes simplex virus DNA cleavage and packaging proteins associate with the procapsid prior to its maturation. J Virol (2001) 2.21

The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA. J Virol (1998) 2.20

The herpes simplex virus 1 UL15 gene encodes two proteins and is required for cleavage of genomic viral DNA. J Virol (1994) 2.14

The herpes simplex virus type 1 cleavage/packaging protein, UL32, is involved in efficient localization of capsids to replication compartments. J Virol (1998) 2.14

Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol (1998) 2.07

Herpes simplex virus type 1 cleavage and packaging proteins UL15 and UL28 are associated with B but not C capsids during packaging. J Virol (1998) 1.91

Assembly of the herpes simplex virus capsid: requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes. J Virol (1995) 1.84

The U(L)15 gene of herpes simplex virus type 1 contains within its second exon a novel open reading frame that is translated in frame with the U(L)15 gene product. J Virol (1997) 1.80

The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity. J Virol (1998) 1.73

Characterization of ICP6::lacZ insertion mutants of the UL15 gene of herpes simplex virus type 1 reveals the translation of two proteins. J Virol (1997) 1.60

A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol (2001) 1.59

Herpes simplex virus DNA cleavage and packaging: association of multiple forms of U(L)15-encoded proteins with B capsids requires at least the U(L)6, U(L)17, and U(L)28 genes. J Virol (1998) 1.58

Packaging of genomic and amplicon DNA by the herpes simplex virus type 1 UL25-null mutant KUL25NS. J Virol (2001) 1.57

DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells. J Virol (2002) 1.51

Herpes simplex virus capsid structure: DNA packaging protein UL25 is located on the external surface of the capsid near the vertices. J Virol (2006) 1.49

Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. J Virol (1999) 1.46

Role of the UL25 gene product in packaging DNA into the herpes simplex virus capsid: location of UL25 product in the capsid and demonstration that it binds DNA. J Virol (2001) 1.43

Evidence for controlled incorporation of herpes simplex virus type 1 UL26 protease into capsids. J Virol (2000) 1.43

Herpes simplex virus type 1 portal protein UL6 interacts with the putative terminase subunits UL15 and UL28. J Virol (2003) 1.37

The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. J Virol (1997) 1.32

Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J Virol (2000) 1.30

The putative terminase subunit of herpes simplex virus 1 encoded by UL28 is necessary and sufficient to mediate interaction between pUL15 and pUL33. J Virol (2006) 1.29

Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J Virol (2007) 1.24

Role of the UL25 protein in herpes simplex virus DNA encapsidation. J Virol (2008) 1.23

Labeling and localization of the herpes simplex virus capsid protein UL25 and its interaction with the two triplexes closest to the penton. J Mol Biol (2010) 1.23

Herpes simplex virus 1 DNA packaging proteins encoded by UL6, UL15, UL17, UL28, and UL33 are located on the external surface of the viral capsid. J Virol (2006) 1.18

Residues of the UL25 protein of herpes simplex virus that are required for its stable interaction with capsids. J Virol (2011) 1.17

Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation. J Virol (2006) 1.16

Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol (1998) 1.15

The UL25 gene product of herpes simplex virus type 1 is involved in uncoating of the viral genome. J Virol (2008) 1.13

Requirement for double-strand breaks but not for specific DNA sequences in herpes simplex virus type 1 genome isomerization events. J Virol (1994) 1.13

ATP depletion blocks herpes simplex virus DNA packaging and capsid maturation. J Virol (1999) 1.10

Effects of mutations within the herpes simplex virus type 1 DNA encapsidation signal on packaging efficiency. J Virol (2001) 1.05

Proteolytic cleavage of the amino terminus of the U(L)15 gene product of herpes simplex virus type 1 is coupled with maturation of viral DNA into unit-length genomes. J Virol (1999) 1.03

Quantification of the DNA cleavage and packaging proteins U(L)15 and U(L)28 in A and B capsids of herpes simplex virus type 1. J Virol (2004) 1.00

Structure of the rat cytomegalovirus genome termini. J Virol (1996) 0.95

Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus. Antimicrob Agents Chemother (2002) 0.94

Characterization of pseudorabies virus (PrV) cleavage-encapsidation proteins and functional complementation of PrV pUL32 by the homologous protein of herpes simplex virus type 1. J Virol (2009) 0.94

Identification, subviral localization, and functional characterization of the pseudorabies virus UL17 protein. J Virol (2005) 0.92

Effects of major capsid proteins, capsid assembly, and DNA cleavage/packaging on the pUL17/pUL25 complex of herpes simplex virus 1. J Virol (2009) 0.91

Polarized DNA ejection from the herpesvirus capsid. J Mol Biol (2009) 0.91

The UL15 protein of herpes simplex virus type 1 is necessary for the localization of the UL28 and UL33 proteins to viral DNA replication centres. J Gen Virol (2008) 0.88

Temperature-sensitive mutations in the putative herpes simplex virus type 1 terminase subunits pUL15 and pUL33 preclude viral DNA cleavage/packaging and interaction with pUL28 at the nonpermissive temperature. J Virol (2007) 0.88

Characterization of mre11 loss following HSV-1 infection. Virology (2008) 0.88

Mutational analysis of the herpes simplex virus type 1 DNA packaging protein UL33. J Virol (2009) 0.87

A "coiled-coil" motif is important for oligomerization and DNA binding properties of human cytomegalovirus protein UL77. PLoS One (2011) 0.87

Inhibition of generation of authentic genomic termini of herpes simplex virus type 1 DNA in temperature-sensitive mutant BHK-21 cells with a mutated CCG1/TAF(II)250 gene. J Virol (1996) 0.87

A mutation in UL15 of herpes simplex virus 1 that reduces packaging of cleaved genomes. J Virol (2011) 0.85

Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents. J Virol (2003) 0.82

Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. J Virol (1998) 0.82

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. Neoplasia (1999) 0.81

Isolation and characterization of the herpes simplex virus 1 terminase complex. J Virol (2013) 0.81

Excision of DNA fragments corresponding to the unit-length a sequence of herpes simplex virus type 1 and terminus variation predominate on one side of the excised fragment. J Virol (1994) 0.81

Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle. J Virol (2014) 0.79

Intracellular Distribution of Capsid-Associated pUL77 of Human Cytomegalovirus and Interactions with Packaging Proteins and pUL93. J Virol (2016) 0.79

The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA. J Virol (2014) 0.76

VirD: a virion display array for profiling functional membrane proteins. Anal Chem (2013) 0.76

Protease-deficient herpes simplex virus protects mice from lethal herpesvirus infection. J Virol (1997) 0.75

Herpes Simplex Virus Capsid Localization to ESCRT-VPS4 Complexes in the Presence and Absence of the Large Tegument Protein UL36p. J Virol (2016) 0.75

Intermolecular Complementation between Two Varicella-Zoster Virus pORF30 Terminase Domains Essential for DNA Encapsidation. J Virol (2015) 0.75

A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes. PLoS One (2014) 0.75

Visualizing Herpesvirus Procapsids in Living Cells. J Virol (2016) 0.75

A domain of Herpes simplex virus pUL33 required to release monomeric viral genomes from cleaved concatameric DNA. J Virol (2017) 0.75

Herpesvirus Capsid Assembly and DNA Packaging. Adv Anat Embryol Cell Biol (2017) 0.75

Articles cited by this

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36

The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25

Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol (1972) 17.28

Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol (1974) 16.33

Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2. J Virol (1972) 11.71

A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods (1981) 10.77

High efficiency DNA-mediated transformation of primate cells. Science (1983) 8.09

Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17. J Gen Virol (1976) 5.47

Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization. Virology (1973) 5.10

Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. J Virol (1983) 4.98

Comparison of the virion proteins specified by herpes simplex virus types 1 and 2. J Virol (1975) 4.39

Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09

Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J Virol (1983) 4.04

Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J Virol (1980) 3.95

The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate. J Virol (1991) 3.80

Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74

Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7). Virology (1982) 3.53

Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol (1987) 3.51

Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J Virol (1984) 2.84

Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J Virol (1993) 2.79

Isolation of a nucleocapsid polypeptide of herpes simplex virus types 1 and 2 possessing immunologically type-specific and cross-reactive determinants. J Virol (1979) 2.78

Characterization of intranuclear capsids made by ts morphogenic mutants of HSV-1. Virology (1988) 2.71

Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65

Characterization of three species of nucleocapsids of equine herpesvirus type-1 (EHV-1). Virology (1975) 2.53

The herpes simplex virus UL33 gene product is required for the assembly of full capsids. Virology (1991) 2.52

Studies of the molecular anatomy of the L-M cell strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion. Virology (1974) 2.39

Fragments from both termini of the herpes simplex virus type 1 genome contain signals required for the encapsidation of viral DNA. Nucleic Acids Res (1983) 2.37

Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids. Virology (1984) 2.35

Genetic and phenotypic characterization of mutants in four essential genes that map to the left half of HSV-1 UL DNA. Virology (1987) 2.21

Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame. Virology (1992) 2.18

Herpes simplex virus type 1 UL28 gene product is important for the formation of mature capsids. J Gen Virol (1990) 2.15

Identification of genes encoding two capsid proteins (VP24 and VP26) of herpes simplex virus type 1. J Gen Virol (1992) 2.14

Some structural antigens of herpes simplex virus type 1. J Gen Virol (1975) 2.04

Identification and characterization of the herpes simplex virus type 1 virion protein encoded by the UL35 open reading frame. J Virol (1992) 1.91

DNA processing in temperature-sensitive morphogenic mutants of HSV-1. Virology (1987) 1.79

Transcription initiation sites and nucleotide sequence of a herpes simplex virus 1 gene conserved in the Epstein-Barr virus genome and reported to affect the transport of viral glycoproteins. J Virol (1986) 1.68

Genetic and phenotypic analysis of herpes simplex virus type 1 mutants conditionally resistant to immune cytolysis. J Virol (1983) 1.66

Electron microscopic studies of temperature-sensitive mutants of herpes simplex virus type 1. Virology (1974) 1.55

Identification of the genes encoding two capsid proteins of herpes simplex virus type 1 by direct amino acid sequencing. J Gen Virol (1990) 1.50

Posttranslational modification and subcellular localization of the p12 capsid protein of herpes simplex virus type 1. J Virol (1992) 1.45

Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production. J Virol (1986) 1.39

The UL5 gene of herpes simplex virus type 1: isolation of a lacZ insertion mutant and association of the UL5 gene product with other members of the helicase-primase complex. J Virol (1992) 1.36

Physical mapping and nucleotide sequence of a herpes simplex virus type 1 gene required for capsid assembly. J Virol (1989) 1.29

Pseudorabies virus protein homologous to herpes simplex virus type 1 ICP18.5 is necessary for capsid maturation. J Virol (1993) 1.19

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication. Antimicrob Agents Chemother (1983) 1.15

The fine structure of cells infected with temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1978) 1.12

Overexpression in bacterial and identification in infected cells of the pseudorabies virus protein homologous to herpes simplex virus type 1 ICP18.5. J Virol (1991) 1.07

Herpesvirus. Intervirology (1986) 1.07

Articles by these authors

Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol (1982) 6.20

Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol (1981) 4.11

The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid. J Virol (2001) 3.65

Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol (1994) 3.24

The herpes simplex virus procapsid: structure, conformational changes upon maturation, and roles of the triplex proteins VP19c and VP23 in assembly. J Mol Biol (1996) 3.20

Assembly of the herpes simplex virus capsid: characterization of intermediates observed during cell-free capsid formation. J Mol Biol (1996) 2.92

Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J Virol (1984) 2.84

The product of the herpes simplex virus type 1 UL25 gene is required for encapsidation but not for cleavage of replicated viral DNA. J Virol (1998) 2.81

Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65

The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol (1987) 2.58

Herpes simplex virus capsids assembled in insect cells infected with recombinant baculoviruses: structural authenticity and localization of VP26. J Virol (1995) 2.15

Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J Virol (1984) 2.09

Cell-free assembly of the herpes simplex virus capsid. J Virol (1994) 1.90

Assembly of the herpes simplex virus capsid: requirement for the carboxyl-terminal twenty-five amino acids of the proteins encoded by the UL26 and UL26.5 genes. J Virol (1995) 1.84

Adult attachment in a nationally representative sample. J Pers Soc Psychol (1997) 1.81

Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J Virol (1999) 1.79

The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1. Virology (1986) 1.71

Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Res (1987) 1.68

Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus. J Virol (1997) 1.57

Attachment styles, emotion regulation, and adjustment in adolescence. J Pers Soc Psychol (1998) 1.52

Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid. J Virol (1998) 1.50

Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins. J Virol (1999) 1.46

Children's religious knowledge: implications for understanding satanic ritual abuse allegations. Child Abuse Negl (1997) 1.44

Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res (1994) 1.42

Adult attachment and the suppression of unwanted thoughts. J Pers Soc Psychol (1997) 1.33

Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. J Virol (1986) 1.33

The pseudorabies virus UL28 protein enters the nucleus after coexpression with the herpes simplex virus UL15 protein. J Virol (1997) 1.32

Attachment theory and intergroup bias: evidence that priming the secure base schema attenuates negative reactions to out-groups. J Pers Soc Psychol (2001) 1.28

Characterization and mapping of a nonessential pseudorabies virus glycoprotein. J Virol (1986) 1.21

A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses. Virology (1994) 1.12

Attachment, attractiveness, and social interaction: a diary study. J Pers Soc Psychol (1996) 1.10

Attachment styles and personality disorders: their connections to each other and to parental divorce, parental death, and perceptions of parental caregiving. J Pers (1998) 1.10

Adult attachment and the defensive regulation of attention and memory: examining the role of preemptive and postemptive defensive processes. J Pers Soc Psychol (2000) 1.10

Assembly of herpes simplex virus capsids using the human cytomegalovirus scaffold protein: critical role of the C terminus. J Virol (1997) 1.10

Resolution of genotypic and phenotypic properties of herpes simplex virus type 1 temperature-sensitive mutant (KOS) tsZ47: evidence for allelic complementation in the UL28 gene. Virology (1993) 1.05

Analysis of the gB promoter of herpes simplex virus type 1: high-level expression requires both an 89-base-pair promoter fragment and a nontranslated leader sequence. J Virol (1992) 1.03

Evaluation of field isolates of pseudorabies (Aujeszky's disease) virus as determined by restriction endonuclease analysis and hybridization. Am J Vet Res (1984) 0.94

A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice. Vaccine (1991) 0.94

Production and characterization of monoclonal antibodies directed against pseudorabies virus. Virus Res (1985) 0.93

Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. Mol Cell Biol (1988) 0.92

Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. J Gen Virol (1989) 0.92

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J Infect Dis (1993) 0.92

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine (1994) 0.90

In vitro assembly of the herpes simplex virus procapsid: formation of small procapsids at reduced scaffolding protein concentration. J Struct Biol (2001) 0.88

Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3. J Gen Virol (1993) 0.87

Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines. J Gen Virol (1993) 0.85

Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity. Vaccine (1993) 0.84

Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein. J Gen Virol (1993) 0.83

Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase. Bioorg Med Chem Lett (2000) 0.82

The bovine herpesvirus 1 maturational proteinase and scaffold proteins can substitute for the homologous herpes simplex virus type 1 proteins in the formation of hybrid type B capsids. J Virol (1995) 0.82

Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1). Adv Exp Med Biol (1990) 0.82

Color association values and response interference on variants of the Stroop test. Acta Psychol (Amst) (1967) 0.80

The UL6 locus of pseudorabies virus and its homology to oncogenic herpesviruses. Oncol Rep (1998) 0.80

Stability of the pseudorabies virus genome after in vivo serial passage. J Gen Virol (1984) 0.80

cDNA cloning, expression, and chromosomal localization of a human UDP-GalNAc:polypeptide, N-acetylgalactosaminyltransferase. J Biochem (1995) 0.79

T cell receptor assembly and expression in the absence of calnexin. Arch Biochem Biophys (2000) 0.76

Validation of an immunoradiometric assay to measure plasma levels of active renin. J Clin Lab Anal (1991) 0.76

Organization of a human UDP-GalNAc:polypeptide, N-acetylgalactosaminyltransferase gene and a related processed pseudogene. Glycobiology (1996) 0.76

Physical mapping of the herpes simplex virus type 2 nuc- lesion affecting alkaline exonuclease activity by using herpes simplex virus type 1 deletion clones. J Virol (1984) 0.75

Phosphorylation of a 25,000-dalton protein in slow and fast muscles of the chicken. Comp Biochem Physiol B (1983) 0.75

Purification of a recombinant human respiratory syncytial virus chimeric glycoprotein using reversed-phase chromatography and protein refolding in guanidine hydrochloride. Protein Expr Purif (1994) 0.75

Assessment of cerebrospinal fluid compliance and outflow resistance: analysis of steady-state response to sinusoidal input. Ann Biomed Eng (1983) 0.75

Transfer of human HPRT gene sequences into neuronal cells by a herpes simplex virus derived vector. Adv Exp Med Biol (1989) 0.75

New antiherpetic 1,3-phenylene derivatives, inhibitors of the interaction of the HSV-1 origin binding protein (OBP) with DNA. Drug Des Discov (2000) 0.75

Restriction endonuclease analysis of the pseudorabies (Aujeszky's disease) virus before and after serial passage in vivo and in vitro. Arch Virol (1983) 0.75

Production, characterization, and utility of monoclonal antibodies which react with a novel chimeric glycoprotein of human respiratory syncytial virus termed FG. Hybridoma (1989) 0.75

Peptides as potential virus inhibitors. Synthesis and bioassay of five respiratory syncytial virus peptide analogs with antimeasles activity. Int J Pept Protein Res (1988) 0.75